The report on Psoriasis Therapeutics Market by molecule (biologics, small molecules), route of administration
(oral, parenteral, topical), dosage forms (solid, liquid, EMI-solid ), mechanism of action (TNF inhibitors, PDE4
inhibitors, il blocker) trends analysis and forecasts up to 2023 studies the market sizes, key trends and
opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World.
According to the report the Global Psoriasis Therapeutics Market is projected to grow at a CAGR of 9.7% in
terms of value over the period of 2017-2023. The growth in the world market is primarily driven by significant
contribution by North America (Leading region) region to this market.
Get a Sample Request:-
https://www.infiniumglobalresearch.com/Reports/MakeSampleRequest/825
Segments Covered
The report on global psoriasis therapeutics market covers segments such as molecule, route of administration,
dosage forms and mechanism of action. The molecule segments include biologics and small molecules. On the
basis of route of administration the global psoriasis therapeutics market is categorized into oral, parenteral
and topical. On the basis of dosage forms the global psoriasis therapeutics market is categorized into solid,
liquid and emi-solid . On the basis of mechanism of action the global psoriasis therapeutics market is
categorized into TNF inhibitors, PDE4 inhibitors ,il blocker and others.
Geographic Coverage
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific and
Rest of the World. In this section the key trends and market size for each geography is provided over the
period of 2015 – 2023.
Infinium Global Research